BR9913722A - Particles for delivering an active agent to the alveoli of a human patient, and method for preparing them, method for delivering an active agent to the lungs of a human patient, and method for increasing the amount of an inhaled active agent deposited in the lung. deep - Google Patents
Particles for delivering an active agent to the alveoli of a human patient, and method for preparing them, method for delivering an active agent to the lungs of a human patient, and method for increasing the amount of an inhaled active agent deposited in the lung. deepInfo
- Publication number
- BR9913722A BR9913722A BR9913722-4A BR9913722A BR9913722A BR 9913722 A BR9913722 A BR 9913722A BR 9913722 A BR9913722 A BR 9913722A BR 9913722 A BR9913722 A BR 9913722A
- Authority
- BR
- Brazil
- Prior art keywords
- active agent
- human patient
- delivering
- lung
- lungs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
"PARTìCULAS PARA FORNECIMENTO DE UM AGENTE ATIVO AOS ALVéOLOS DE UM PACIENTE HUMANO, E MéTODO PARA A PREPARAçãO DAS MESMAS, MéTODO PARA FORNECIMENTO DE UM AGENTE ATIVO AOS PULMõES DE UM PACIENTE HUMANO, E MéTODO PARA AUMENTAR A QUANTIDADE DE UM AGENTE ATIVO INALADO DEPOSITADO NO PULMãO PROFUNDO". A presente invenção é dirigida a composições particuladas e a métodos para o fornecimento de um ingrediente ativo ao pulmão de um paciente humano. A formulação de agente ativo está sob a forma de pó seco e exibe (i) sorção de baixa umidade, e (ii) resistência ao crescimento higroscópico, particularmente sob condições de pulmão simuladas."PARTICLES FOR SUPPLYING AN ACTIVE AGENT TO THE HANDLES OF A HUMAN PATIENT, AND METHOD FOR THE PREPARATION OF THE SAME, METHOD FOR SUPPLYING AN ACTIVE AGENT TO THE LUNGS OF A HUMAN PATIENT, AND METHOD FOR THE QUANTUM OF QUANTUM OF QUANTUM OF QUANTUM OF QUANTITATIVE DEEP LUNG ". The present invention is directed to particulate compositions and methods for delivering an active ingredient to the lung of a human patient. The active agent formulation is in the form of dry powder and exhibits (i) low moisture sorption, and (ii) resistance to hygroscopic growth, particularly under simulated lung conditions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10016398P | 1998-09-14 | 1998-09-14 | |
| PCT/US1999/021109 WO2000015262A1 (en) | 1998-09-14 | 1999-09-13 | Dry powder active agent pulmonary delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9913722A true BR9913722A (en) | 2001-05-29 |
Family
ID=22278404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9913722-4A BR9913722A (en) | 1998-09-14 | 1999-09-13 | Particles for delivering an active agent to the alveoli of a human patient, and method for preparing them, method for delivering an active agent to the lungs of a human patient, and method for increasing the amount of an inhaled active agent deposited in the lung. deep |
Country Status (44)
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1198593C (en) | 1999-06-09 | 2005-04-27 | 罗伯特·E·希弗斯 | Supercritical fluid-assisted nebulization and bubble drying |
| US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| CN1671643B (en) | 2002-02-25 | 2013-05-29 | 扩散药品有限公司 | Bipolar trans carotenoid salts and their uses |
| WO2004004798A2 (en) * | 2002-07-03 | 2004-01-15 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
| MXPA05006802A (en) * | 2002-12-19 | 2005-09-08 | Pharmacia Corp | Non-hygroscopic formulation comprising a hydroscopic drug. |
| DE10338403A1 (en) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant |
| GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| MXPA06012240A (en) | 2004-04-23 | 2007-01-31 | Cydex Inc | Dpi formulation containing sulfoalkyl ether cyclodextrin. |
| EP2540696B1 (en) * | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
| KR20070110418A (en) * | 2005-03-09 | 2007-11-16 | 오노 야꾸힝 고교 가부시키가이샤 | Particle and preparation containing the particle |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| MX348982B (en) | 2005-10-26 | 2017-07-06 | Cydex Pharmaceuticals Inc | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof. |
| US20100269819A1 (en) * | 2006-08-14 | 2010-10-28 | Sievers Robert E | Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions |
| US20100093875A1 (en) * | 2006-10-25 | 2010-04-15 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
| EP1925295A1 (en) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
| EP3483140A1 (en) | 2007-04-13 | 2019-05-15 | Diffusion Pharmaceuticals LLC | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
| CN101878040A (en) | 2007-10-31 | 2010-11-03 | 扩散药品有限公司 | A new class of therapeutics that enhance small molecule diffusion |
| US9610343B2 (en) * | 2009-05-20 | 2017-04-04 | Aeras Global Tb Vaccine Foundation | Stable, spray dryed, immunogenic, viral compositions |
| CN108464976A (en) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | Diffusion promotes compound and its independent or application together with Thrombolytic Drugs |
| US8974822B2 (en) | 2010-06-02 | 2015-03-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
| JP6349304B2 (en) | 2012-05-03 | 2018-06-27 | ヤンセン・サイエンシズ・アイルランド・ユーシー | Polyinosine-polycytidylic acid (poly (I: C)) formulation for the treatment of upper respiratory tract infections |
| BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
| WO2015042352A1 (en) * | 2013-09-20 | 2015-03-26 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
| EP3212212B1 (en) | 2014-10-31 | 2020-09-23 | Monash University | Powder formulation |
| KR102489034B1 (en) | 2016-03-24 | 2023-01-13 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
| WO1993025198A1 (en) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
| US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| WO1998031346A1 (en) * | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Application Discontinuation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Application Discontinuation
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-03-14 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown
-
2002
- 2002-03-06 HK HK02101738.3A patent/HK1042231A1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9913722A (en) | Particles for delivering an active agent to the alveoli of a human patient, and method for preparing them, method for delivering an active agent to the lungs of a human patient, and method for increasing the amount of an inhaled active agent deposited in the lung. deep | |
| NO20025873D0 (en) | Very effective delivery of a large therapeutic amount of aerosol | |
| ATE363892T1 (en) | IMPROVED POWDER FORMULATIONS FOR INHALATION | |
| PT1061901E (en) | NICOTINE INHALER | |
| DE59914603D1 (en) | Multidose dry powder inhaler with powder reservoir | |
| CA2389349A1 (en) | Aerosol composition comprising formoterol | |
| TR200101033T2 (en) | Flow resistance reduced, delivery of aerosol active substance | |
| JO2430B1 (en) | Pharmaceuticall Formulations for Dry Powder Inhalers in the form of Hard- Pellets | |
| MY129384A (en) | "pharmaceutical formulations for dry powder inhalers in the form of hard-pellets" | |
| Ruijgrok et al. | Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats | |
| Ferron | Aerosol properties and lung deposition | |
| DE69806362D1 (en) | THERAPEUTIC POWDER FORMULA FOR PULMONARY APPLICATION, WHICH CONTAINS CRYSTALLINE INSULIN | |
| NO20051463L (en) | Inhalation compositions with high drug content | |
| EE04038B1 (en) | Formoterol inhalation dosage form, bulk density 0.28 to 0.38 g / ml, method of preparation and use | |
| BR0013250A (en) | Formulations of aqueous suspension of spinosyn ectoparasiticide | |
| AU5886896A (en) | Modified animal lung surfactant and its therapeutic use | |
| JPS60215092A (en) | Powdery aerosol composition to be applied to the human body | |
| Miller et al. | Inhibition of hamster buccal pouch carcinogenesis by green coffee beans | |
| EE03950B1 (en) | Inhalable terbutaline sulphate dosage form, bulk density 0.28 to 0.38 g / ml, method of preparation and use | |
| CA2265198A1 (en) | Method of producing a nicotine medicament and a medicament made by the method | |
| Homburger et al. | Cigarette smoke inhalation studies in inbred Syrian hamsters | |
| JP2002161030A (en) | Method for inhaling mixed powder having different particle diameter | |
| TH59260B (en) | Dosing of the active ingredient that has been aerosolized | |
| JP2000086480A (en) | Chapped skin treating cosmetic | |
| JPS61233610A (en) | Incense or incense stick having medicinal effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009. |